Eli Malakan
@Union Square Park Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$137.772MTotal holdings27
Assets growth rate22.12%Assets growth rate (2-Q avg)5.97%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Union Square Park Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 27 positions.
Assets under management
The assets under management (AUM) of Union Square Park Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 137.772M in assets, with a quarterly growth rate of 22.12% and a 2-quarter average growth rate of 5.97%. The portfolio is managed by Eli Malakan, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
GEVGe Vernova Inc
| 5.56% | $7.649M↑ Call 30,000 shares@ $254.98 avg price | New Position |
FWRDForward Air Corp
| 4.24% | $5.841M 165,000 shares@ $35.4 avg price | New Position |
UPWKUpwork Inc
| 2.47% | $3.396M 325,000 shares@ $10.45 avg price | New Position |
AIVApartment Invt & Mgmt Co
| 1.55% | $2.124M 235,000 shares@ $9.04 avg price | New Position |
CVSCvs Health Corp
| 0.92% | $1.258M 20,000 shares@ $62.88 avg price | New Position |
PETWag Group Co
| 0.63% | $860,000 1M shares@ $0.86 avg price | New Position |
MGNIMagnite Inc
| 0.51% | $692,500 50,000 shares@ $13.85 avg price | New Position |
RMAXRe Max Hldgs Inc
| 0.5% | $684,750 55,000 shares@ $12.45 avg price | New Position |
EGRXEagle Pharmaceuticals Inc
| 0.16% | $212,472 56,963 shares@ $3.74 avg price | New Position |